Judith de Vos‐Geelen

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Eva Versteijne, Mustafa Suker, Karin Groothuis et al. · Journal of Clinical Oncology · 2020 · 1K citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

Anouk E.J. Latenstein, Lydia G. van der Geest, Bert A. Bonsing et al. · European Journal of Cancer · 2019 · 160 citations · Full text

Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.

Geertjan van Tienhoven, Eva Versteijne, Mustafa Suker et al. · Journal of Clinical Oncology · 2018 · 159 citations

Surgical Oncology, Gastroenterology, Adjuvant Chemotherapy +17

Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

Marin Strijker, Ali Belkouz, Lydia G. van der Geest et al. · Acta Oncologica · 2019 · 116 citations · Full text